Background Anti-coagulant therapy satisfaction for patients with atrial fibrillation is a critical
issue, which impacts on their treatment adherence and clinical outcomes. The …

Objective We compared the effectiveness and safety outcomes of non-vitamin K antagonist
oral anticoagulants (NOACs) and warfarin in patients with AF and VHD, as these patients …

BACKGROUND Since 2010, the European Society of Cardiology has extended prescription
criteria for oral antithrombotic therapy (OAT) in atrial fibrillation (AF). Direct oral …

Thromboembolic events are a common risk in adults with atrial fibrillation, those with
previous cerebrovascular accidents and undergoing emergency or elective surgeries. The …

Introduction: Atrial fibrillation (AF) is associated with an increased risk of thromboembolic
events. Many patients with AF receive chronic anticoagulation, either with vitamin K …

Objective Long-term adherence to evidence-based medications in cardiometabolic diseases
remains poor, despite extensive efforts to develop and test interventions and deploy clinician …

Basic coagulation tests, activated partial thromboplastin time (APTT), prothrombin time (PT)
and the related international normalised ratio (INR), are performed frequently in hospital …

Purpose The purpose of this study was to investigate the influence of patient characteristics
such as age and stroke and bleeding risks on decisions for antithrombotic treatment in …

Coagulopathy and bleeding are common in patients undergoing cardiac surgery, with a
perioperative transfusion rate in excess of 50%. The mechanism of coagulopathy associated …

Importance Numerous factors are associated with the ability of patients with type 2 diabetes
to achieve optimal glycemic control. However, many of these factors are not modifiable by …